Skip to main content
HR 1973 110th Congress House Health Centers for Disease Control and Prevention (CDC) Civil Rights and Liberties, Minority Issues Clinical trials Communication in medicine Communication in science Conflict of interests Congressional reporting requirements Data banks Department of Health and Human Services Drug approvals Drug industry Economics and Public Finance Executive reorganization Federal advisory bodies Federal aid to research Government Operations and Politics Government paperwork Government publicity Health information systems

Vaccine Safety and Public Confidence Assurance Act of 2007

Introduced: April 19, 2007 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 20, 2007
Referred to the Subcommittee on Health.
Apr 19, 2007
Referred to the House Committee on Energy and Commerce.
Apr 19, 2007
Introduced in House
 Plain-English summary Congressional Research Service

Vaccine Safety and Public Confidence Assurance Act of 2007 - Amends the Public Health Service Act to establish the Agency for Vaccine Safety Evaluation in the Office of the Secretary of Health and Human Services. Requires the Director for Vaccine Safety Evaluation to: (1) conduct or support safety research and monitor licensed vaccines; (2) develop a vaccine safety research agenda; (3) evaluate means to promote compliance with federal adverse reaction reporting requirements; (4) provide a clearinghouse for vaccine studies; (5) ensure that functions relating to vaccine monitoring or research on adverse reactions are not carried out by anyone with a conflict of interest; (6) oversee the Vaccine Safety Datalink Project; and (7) resolve U.S. conflicts of interest related to international agreements, partnerships, and activities.

Allows the Director to establish a program of awarding fellowships for research on vaccine safety.

Requires the Commissioner of Food and Drugs to provide the Director, upon request, with complete access to all vaccine-related information submitted to the Food and Drug Administration (FDA) by vaccine manufacturers.

Requires the Director to require vaccine manufacturers to: (1) provide for postmarketing surveillance and clinical testing for any acute or chronic adverse reactions associated with the vaccine; and (2) register in a qualified public registry each clinical trial conducted or supported by the manufacturer with respect to the vaccine.

Transfers to the Agency Centers for Disease Control and Prevention (CDC) responsibilities for the Vaccine Safety Datalink Project, the Clinical Immunization Safety Assessment Centers, or any other post-licensure vaccine safety monitoring activities.

Requires the Secretary to establish an advisory council in the Agency.

What's happening now April 20, 2007

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2